AARTI DRUGS
Back to Balance Sheet
|
AARTI DRUGS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹368 Cr | ₹355 Cr | ₹279 Cr | ₹232 Cr | ₹257 Cr |
What is the latest Total Non-Current Liabilities ratio of AARTI DRUGS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹368 Cr |
| Mar2024 | ₹355 Cr |
| Mar2023 | ₹279 Cr |
| Mar2022 | ₹232 Cr |
| Mar2021 | ₹257 Cr |
How is Total Non-Current Liabilities of AARTI DRUGS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹368 Cr | 3.81 | |
| Mar2024 | ₹355 Cr | 27.08 | |
| Mar2023 | ₹279 Cr | 20.58 | |
| Mar2022 | ₹232 Cr | -9.97 | |
| Mar2021 | ₹257 Cr | - | |
Compare Total Non-Current Liabilities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,803.1 Cr | 9.1% | -5.9% | 0.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | 9.1% |
-5.9% |
0.1% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses